Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening

Por Bulkmans, N W J, Rozendaal, L, Voorhorst, F J, Snijders, P J F, Meijer, C J L M
Publicado em 2005

Cross-Sectional Comparison of an Automated Hybrid Capture 2 Assay and the Consensus GP5+/6+ PCR Method in a Population-Based Cervical Screening Program

Por Hesselink, A. T., Bulkmans, N. W. J., Berkhof, J., Lorincz, A. T., Meijer, C. J. L. M., Snijders, P. J. F.
Publicado em 2006

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

Por Coupé, V M H, Berkhof, J, Bulkmans, N W J, Snijders, P J F, Meijer, C J L M
Publicado em 2008

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands

Por Bulk, S, Berkhof, J, Bulkmans, N W J, Zielinski, G D, Rozendaal, L, van Kemenade, F J, Snijders, P J F, Meijer, C J L M
Publicado em 2006

High-risk HPV type-specific clearance rates in cervical screening

Por Bulkmans, N W J, Berkhof, J, Bulk, S, Bleeker, M C G, van Kemenade, F J, Rozendaal, L, Snijders, P J F, Meijer, C J L M
Publicado em 2007

Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate

Por Bulkmans, N W J, Bulk, S, Ottevanger, M S, Rozendaal, L, Hellenberg, S M, van Kemenade, F J, Snijders, P J F, Boeke, A J P, Meijer, C J L M
Publicado em 2006